Tandem Diabetes Care (TNDM) FCF Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 194.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 984.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 641.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 66.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 119.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1,788.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -177.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -395.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -473.00 |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | -862.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -862.00 |
| Mar 31, 2026 | 1,061.00 |
| Dec 31, 2025 | -164.00 |
| Sep 30, 2025 | -716.00 |
| Jun 30, 2025 | -72.00 |
| Mar 31, 2025 | -309.00 |
| Dec 31, 2024 | 901.00 |
| Sep 30, 2024 | 1,171.00 |
| Jun 30, 2024 | 170.00 |
| Mar 31, 2024 | 953.00 |
| Dec 31, 2023 | -640.00 |
| Sep 30, 2023 | -788.00 |
| Jun 30, 2023 | -439.00 |
| Mar 31, 2023 | -2,237.00 |
| Dec 31, 2022 | -653.00 |
| Sep 30, 2022 | -1,228.00 |
| Jun 30, 2022 | -1,834.00 |
| Mar 31, 2022 | -1,150.00 |
| Dec 31, 2021 | -2.00 |
| Sep 30, 2021 | 1,097.00 |